and targeted therapies
for the treatment of
Pascal Biosciences is dedicated to improving the lives of patients suffering from life-threatening diseases such as glioblastoma and other intractable cancers. We are developing novel cannabinoid-based small molecules and targeted antibodies, focusing on cancers for which there are no adequate therapies.
Pascal Biosciences Partners with Mitacs to Support Innovative Cancer Research at University of British Columbia
March 18, 2019Read More